{"id":"NCT01456897","sponsor":"Otsuka Pharmaceutical Co., Ltd.","briefTitle":"A Long-term Trial of OPC-34712 in Patients With Schizophrenia","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10","primaryCompletion":"2015-05","completion":null,"firstPosted":"2011-10-21","resultsPosted":"2019-12-30","lastUpdate":"2019-12-30"},"enrollment":282,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Schizophrenia"],"interventions":[{"type":"DRUG","name":"OPC-34712","otherNames":[]}],"arms":[{"label":"OPC-34712","type":"EXPERIMENTAL"}],"summary":"To investigate the safety and efficacy of long-term administration of OPC-34712 in patients with schizophrenia.","primaryOutcome":{"measure":"Percentage of Participants With Adverse Events","timeFrame":"From Baseline up to 52 Weeks","effectByArm":[{"arm":"New Subjects","deltaMin":156,"sd":null},{"arm":"Rollover Subjects","deltaMin":79,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":["32297486"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":19,"n":183},"commonTop":["Nasopharyngitis","Schizophrenia","Akathisia","Headache","Weight increased"]}}